Pompe Telemedicine Developmental Study



Status:Recruiting
Conditions:Diabetes
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:6 - 18
Updated:11/23/2018
Start Date:December 2015
End Date:July 2019
Contact:Stephanie Austin
Email:stephanie.austin@duke.edu
Phone:919-668-1347

Use our guide to learn which trials are right for you!

Developmental Outcomes of School-aged Children With Infantile-onset Pompe Disease: A Telemedicine Approach to Assessment and Cognitive Training

The primary purpose of this study is to:

- Document the developmental outcomes of individuals with Pompe disease treated with
long-term enzyme-replacement therapy (ERT) through school-age (ages 6-18) using measures
of cognitive functioning, academic skills, and speech and language abilities.

- Investigate possible cognitive processing speed weaknesses using BrainBaseline
neurocognitive assessment software.

- Investigate the relationship between behavior and other developmental factors including
speech and language ability and cognitive ability.

- Explore if the use of selected iPad applications may help strengthen cognitive
processing speed in children with Pompe disease

The study will last approximately 2-3 years. It includes 2-4 visits to Duke for developmental
assessments. The baseline/year 1 visit may take place at Duke (may take 1-2 days) or remotely
via iPad. The follow up 1/year 2 visit may take place at Duke (1-2 days) or remotely via an
iPad, depending upon each child's particular situation.

Inclusion Criteria:

- Age range 6-18 years

- Diagnosis of classic Pompe disease by enzyme or molecular methods

- Patient, parent, or legal guardian is willing and able to give written informed
consent

- English speaking child and care giver.

Exclusion Criteria:
We found this trial at
1
site
2301 Erwin Rd
Durham, North Carolina 27710
919-684-8111
Duke Univ Med Ctr As a world-class academic and health care system, Duke Medicine strives...
?
mi
from
Durham, NC
Click here to add this to my saved trials